Mironid

A bright future for patients with rare kidney disease

Glasgow, United Kingdom · Founded 2019 · $91.4M raised

Headquarters
Glasgow
Employees
11–50
Founded
2019
Business Model
B2B
Total Funding
$91.4M
Last Round
$43.9M Series BAug 2026
Rounds
3

Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.

About

Mironid is a clinical-stage biopharmaceutical company developing novel small-molecule therapeutics that target cAMP-degrading phosphodiesterase (PDE4) enzymes for rare kidney and lung diseases, with a primary focus on Autosomal Dominant Polycystic Kidney Disease (ADPKD). The company's pipeline includes PDE4 activators and inhibitors designed to modulate central signalling mechanisms that drive ADPKD and inflammatory/fibrotic lung conditions, addressing diseases with significant unmet medical need. Headquartered in Glasgow, UK, Mironid is backed by Epidarex Capital and is building a differentiated pipeline of drug candidates across multiple rare disease indications.

Summary

Mironid is a Biotech company based in Glasgow, United Kingdom, founded in 2019. It has raised $91.4M in total across 3 rounds, most recently a $43.9M Series B round in Aug 2026. Investors include Sofinnova Partners, Epidarex Capital and BioGeneration Ventures.

Tech & App Stack

3 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

Series BSeries BAug 2026
$43.9M

Sign up to see all 3 events

Funding: Series A through Series B. Amounts, valuations, and investors where available.

Investors

Similar Companies

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Mironid on Indexed.vc
<a href="https://indexed.vc/companies/mironid"><img src="https://indexed.vc/api/badge/company/mironid" alt="Mironid on Indexed.vc" width="260" height="76" /></a>